Skip to main content
NRIX logo

NRIX · Nurix Therapeutics, Inc. · Analyst Estimates

Track NRIX — free
$22.99 -0.35 (-1.50%) At close · Oct 2
Market Cap
$2.39B
Shares
103.78M
Volume · Oct 2 815.51K Avg daily vol (3M) 1.26M

Analyst Estimates

Compare analyst forecasts for Nurix Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 20:44 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-11-30

Analyst estimates for FY ending 2026-11-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
3.02873
3.37624
3.82
—
1.78718
-2.85812
1.78718
-2.94717
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
0
2
0
Revenue
USD
Publication date not stated
736000000
755336460
790300000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

FY ending 2027-11-30

Analyst estimates for FY ending 2027-11-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.83
-1.06532
-0.68
—
-1.43899
-2.72809
-1.43899
-2.86421
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
3
0
Revenue
USD
Publication date not stated
58000000
120761460
200000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-08-31

Analyst estimates for Q ending 2026-08-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
4.29107
5.11369
5.74
—
5.11369
-0.69698
5.11369
-0.73692
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
2
0
Revenue
USD
Publication date not stated
25000000
479521500
713564500
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

Q ending 2026-11-30

Analyst estimates for Q ending 2026-11-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.64
-0.36859
-0.10576
—
-0.36859
-0.66852
-0.36859
-0.72682
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
2
0
Revenue
USD
Publication date not stated
21000000
265373500
750000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —
Key facts CIK 1549595 CUSIP 67080M103 13F (30d) 4 filings 4 filers Visit website Investor relations